BioCo Hungary Ltd. was sold to Ceres Pharma, aiming to enhance international growth opportunities within the expanding dietary supplement market.

Information on the Target

BioCo Hungary Ltd. has established itself as a key player in the domestic vitamin and dietary supplement market. The company has been led and developed by owners and managers Nikolett Sántáné Urbán and Judit Szép for nearly two decades, maintaining tight control over product development, manufacturing, quality assurance, and sales. In October 2025, BioCo was sold to Ceres Pharma, a pharmaceutical distributor based in Belgium, with Heal Partners acting as the advisory partner on the seller's side.

The owners expressed that their vision centered around building a high-quality product range and a strong Hungarian brand, which ultimately led to the decision to sell the company at this time.

Industry Overview in Hungary

The vitamin and dietary supplement industry in Hungary has seen consistent growth, driven by an increasing consumer focus on health and wellness. As awareness of preventive healthcare rises, the demand for vitamin and su

View Source

Similar Deals

ルネサンス マイリハ

2026

Other Residential & Long-Term Care Japan
Vipulse Technology Kft. SIIX Hungary Kft.

2026

Other Electronic Components Hungary
Edwards Lifesciences JenaValve Technology

2026

Other Medical Devices & Implants United States of America
くすりの窓口 メディ・ウェブ

2026

Other Healthcare Facilities & Services (NEC) Japan

Ceres Pharma

invested in

BioCo Magyarország Kft.

in 2025

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert